American Society for Clinical Pharmacology and Therapeutics - 123rd Annual Meeting. Virtual - March 16-18, 2022
Drugs of the Future
; 47(5):381-385, 2022.
Article
in English
| EMBASE | ID: covidwho-1957096
ABSTRACT
The 2022 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting held virtually, with "Disruptive innovation" as the motto, offered attendees an outstanding scientific program focused on clinical pharmacology, translational medicine, drug discovery and drug development. It is the most important event for scientists involved in clinical pharmacology and translational medicine. The ASCPT conference offers scientists from different professional scopes and around the world the perfect opportunity to discuss emerging science. It focuses on improving the understanding and use of existing drug therapies and developing safer and more effective treatments for the future. Oral and poster presentations were available for participants during the running of the conference to accommodate the different time zones. Presentations covered the latest research with the option to ask questions after each presentation via a chat function. Discussion boards were available to provide networking opportunities for virtual attendees.
NCT03234712; NCT03950960; NCT04452318; 5' nucleotidase; adenosine A2a receptor antagonist; afimetoran; amg 119; casirivimab; gs 1423; imdevimab; immunoglobulin G1 antibody; immunomodulating agent; incb 106385; itraconazole; nirmatrelvir; povorcitinib; remdesivir; savolitinib; serclutamab talirine; transforming growth factor beta; vupanorsen; article; cancer patient; clinical evaluation; clinical pharmacology; coronavirus disease 2019; drug bioavailability; drug development; drug dose escalation; drug therapy; first in human study; human; medical research; medical society; multicenter study (topic); pharmacokinetics; phase 1 clinical trial (topic); phase 3 clinical trial (topic); randomized controlled trial (topic); scientist; solid malignant neoplasm; therapy; translational medicine; abbv 321
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
Drugs of the Future
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS